Net Cash Provided by (Used in) Investing Activities of ORAMED PHARMACEUTICALS INC. from 30 Nov 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
ORAMED PHARMACEUTICALS INC. quarterly and annual Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 30 Nov 2010 to 31 Mar 2025.
  • ORAMED PHARMACEUTICALS INC. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2025 was $23,616,000, a 21% decline year-over-year.
  • ORAMED PHARMACEUTICALS INC. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $105,817,000.
  • ORAMED PHARMACEUTICALS INC. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $73,038,000, a 342% decline from 2022.
  • ORAMED PHARMACEUTICALS INC. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $30,211,000.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $23,616,000 -$6,382,000 -21% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $29,998,000 +$43,201,000 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $13,203,000 -$20,562,000 -279% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $7,359,000 -$3,394,000 -32% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $99,248,000 -$96,843,000 -4027% 01 Sep 2021 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q1 2021 $10,753,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $2,405,000 -$5,230,000 -185% 01 Sep 2020 31 Dec 2020 10-QT 30 Mar 2022 2021 Q2
Q4 2019 $2,825,000 -$170,000 -5.7% 01 Sep 2019 30 Nov 2019 10-Q 14 Jan 2021 2021 Q1
Q4 2018 $2,995,000 +$8,141,000 01 Sep 2018 30 Nov 2018 10-Q 09 Jan 2020 2020 Q1
Q4 2017 $5,146,000 -$1,710,000 -50% 01 Sep 2017 30 Nov 2017 10-Q 14 Jan 2019 2019 Q1
Q4 2016 $3,436,000 -$4,254,000 -520% 01 Sep 2016 30 Nov 2016 10-Q 11 Jan 2018 2018 Q1
Q4 2015 $818,000 -$658,000 -45% 01 Sep 2015 30 Nov 2015 10-Q 11 Jan 2017 2017 Q1
Q4 2014 $1,476,000 +$1,638,000 01 Sep 2014 30 Nov 2014 10-Q 13 Jan 2016 2016 Q1
Q4 2013 $162,000 -$616,227 -136% 01 Sep 2013 30 Nov 2013 10-Q 08 Jan 2015 2015 Q1
Q4 2012 $454,227 +$5,288 +1.2% 01 Sep 2012 30 Nov 2012 10-Q 14 Jan 2014 2014 Q1
Q4 2011 $448,939 +$348,939 +349% 01 Sep 2011 30 Nov 2011 10-Q 26 Dec 2012 2013 Q1
Q4 2010 $100,000 01 Sep 2010 30 Nov 2010 10-Q 12 Jan 2012 2012 Q1

ORAMED PHARMACEUTICALS INC. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $105,817,000 +$178,855,000 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $73,038,000 -$103,249,000 -342% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $30,211,000 +$53,975,000 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
2021 $23,764,000 -$28,390,000 -614% 01 Sep 2020 31 Aug 2021 10-K 06 Mar 2023 2022 FY
2020 $4,626,000 -$6,633,000 -59% 01 Sep 2019 31 Aug 2020 10-K 24 Nov 2021 2021 FY
2019 $11,259,000 +$18,263,000 01 Sep 2018 31 Aug 2019 10-K 24 Nov 2020 2020 FY
2018 $7,004,000 -$11,306,000 -263% 01 Sep 2017 31 Aug 2018 10-K 27 Nov 2019 2019 FY
2017 $4,302,000 +$20,312,000 01 Sep 2016 31 Aug 2017 10-K 27 Nov 2019 2019 FY
2016 $16,010,000 -$12,698,000 -383% 01 Sep 2015 31 Aug 2016 10-K 28 Nov 2018 2018 FY
2015 $3,312,000 +$9,776,000 +75% 01 Sep 2014 31 Aug 2015 10-K 29 Nov 2017 2017 FY
2014 $13,088,000 -$8,519,000 -186% 01 Sep 2013 31 Aug 2014 10-K 25 Nov 2016 2016 FY
2013 $4,569,000 -$6,338,000 -358% 01 Sep 2012 31 Aug 2013 10-K 25 Nov 2015 2015 FY
2012 $1,769,000 +$3,472,430 01 Sep 2011 31 Aug 2012 10-K 14 Nov 2014 2014 FY
2011 $1,703,430 01 Sep 2010 31 Aug 2011 10-K 12 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.